查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1803694

心臟結構器材市場按產品類型、手術類型、材料類型、應用和最終用戶分類－2025-2030 年全球預測

Structural Heart Devices Market by Product Type, Procedure Type, Material Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計 2024 年心臟結構器材市場價值將達到 210.6 億美元，2025 年將成長至 230.1 億美元，複合年成長率為 9.60%，到 2030 年將達到 365.1 億美元。

主要市場統計數據
基準年2024年 210.6億美元
預計2025年 230.1億美元
預測年份 2030 365.1億美元
複合年成長率（%） 9.60%

心臟結構器械的創新正在重塑心臟治療的格局，為患有瓣膜疾病、閉鎖和複雜解剖學問題的患者帶來新的希望。隨著人口結構變化推動對微創治療的需求，醫療技術開發人員不斷改進輸送系統和材料，以提高手術安全性和患者療效。同時，監管機構也不斷改善核准途徑，以加速突破性解決方案的核准，凸顯了創新與政策之間的重要交互作用。

近年來，經導管技術的進步以及機械瓣膜和組織瓣膜設計的改進顯著提高了瓣膜的耐用性和動態性能。這些技術突破與成像方式和導管導引線系統的改進相得益彰，使得瓣膜置入更加精準，並縮短了恢復時間。因此，醫院和心臟專科中心擴大採用整合的手術通訊協定，利用這些工具來最佳化持續治療。

經濟壓力和不斷變化的報銷模式凸顯了在不犧牲品質的情況下提高成本效益的重要性。因此，製造商正在探索從先進聚合物到生物相容性合金等新材料，同時也正在投資下一代導引鞘和封堵器配置。這些發展凸顯了推動該領域發展的多方面力量。

本執行摘要全面介紹了變革性的市場變化、關稅影響、細分洞察、區域動態和策略建議，旨在為決策者提供資訊並指南未來對結構性心臟設備創新的投資。

識別由生態系統範圍的技術進步、以患者為中心的醫療保健趨勢和監管里程碑推動的結構性心臟護理的變革性模式轉移

結構性心臟器械領域正在經歷一場變革性的模式轉移，這得益於技術突破、以患者為中心的護理模式以及不斷發展的法律規範的共同推動。隨著人工智慧和機器學習開始與器械開發交叉，預測分析正在實現更準確的患者選擇和個人化治療通訊協定。這種向數據主導決策的轉變與3D列印技術的擴展相輔相成，3D列印技術促進了針對特定患者的植入設計和快速原型製作。

評估美國關稅對心臟結構器械供應鏈、成本結構、營運彈性和戰略製造決策的深遠影響

美國關稅將於2025年生效，這將對心臟結構器械供應鏈產生重大影響，並促使整個產業進行策略調整。嚴重依賴進口零件的製造商面臨著不斷上升的投入成本，尤其是從海外供應商採購的專用金屬合金和聚合物材料。這些不斷上升的採購成本將迫使他們要么消化增加的成本，要么將負擔轉嫁給下游企業，這可能會擾亂定價和報銷談判。

透過解讀關鍵細分維度來洞察產品、流程、材料、應用和最終用戶，推動結構性心臟設備策略和成果

關鍵細分洞察揭示了產品、流程、材料、應用和最終用戶維度中的細微機遇，每個機會都為有針對性的策略舉措提供資訊。按產品類型設備配件，包括輸送系統、導管導引線和導引鞘在內的附件設備展現了模組化創新的價值；而包括機械、組織和經導管類型在內的心臟瓣膜設備則凸顯了人們對微創植入日益成長的偏好。封堵器和閉合裝置，包括房間隔缺損封堵器和左心耳封堵解決方案，進一步凸顯了經皮治療範圍的不斷擴大。

了解影響美洲、中東和非洲以及亞太市場結構性心臟設備採用模式的區域動態和成長動力

結構性心臟器材領域的區域動態呈現出美洲、歐洲、中東和非洲地區以及亞太地區獨特的成長動力和應用模式。在美洲，先進的醫療基礎設施和成熟的報銷模式支持著下一代經導管療法的快速整合。領先的醫院和專科中心正在大力投資多學科團隊和高保真影像處理設備，創造有利於手術創新和臨床試驗的環境。同時，門診手術中心擴大參與微創項目，擴大了醫療服務的可近性並降低了整體成本。

揭示領先製造商的策略舉措和競爭格局。創新與夥伴關係正在重塑結構性心臟器材的格局。

領先的製造商正採取大膽舉措，透過創新、策略聯盟和有針對性的收購來保持競爭優勢。在瓣膜技術領域擁有傳統優勢的公司持續投資下一代經導管解決方案，利用數十年的臨床數據來支援器械的改進。同時，新興企業正憑藉顛覆性材料和獨特的部署機制進入市場，並與研究機構夥伴關係，以加速臨床前檢驗。

最大化市場地位的策略藍圖：加速成長、加強合作、推動結構性心臟設備創新的可行建議

為了因應不斷變化的結構性心臟器材市場環境，產業領導者應優先整合數位健康解決方案，啟用遠端監控平台和預測分析，為患者選擇和術後管理提供參考​​。此類投資將推動臨床療效的改善，並透過持續的數據回饋循環提升器械的長期性能。此外，透過雙籌資策略實現供應鏈多元化，並建立區域製造中心，將增強企業在關稅波動和物流中斷情況下的韌性。

揭示全面的結構性心臟裝置分析背後的嚴​​謹調查方法，從資料收集到檢驗、綜合和專家評審

本次結構性心臟器材分析背後的調查方法結合了嚴格的一手資料和二次研究階段，以確保研究的全面覆蓋和資料的完整性。一手資料研究包括對不同醫療機構的心臟病專家、介入科醫生和採購主管的深入訪談，以及對行業相關人員的調查，以了解他們對技術趨勢、關稅影響和區域動態的看法。

重點摘要，突顯心臟結構裝置趨勢、策略挑戰、創新驅動力以及相關人員和決策者的未來方向

本執行摘要揭示了影響結構性心臟器械產業的關鍵趨勢，從變革性的技術變革到即將到來的關稅政策的細微差別。細分洞察強調了程序偏好、材料創新以及針對不同最終用戶需求量身定做的產品開發的重要性。區域分析揭示了成熟市場和新興市場中不同的應用動態，凸顯了商機。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 在結構性心臟器械的設計和交付中，越來越注重針對患者的客製化
  • 心血管疾病盛行率上升推動對創新心臟設備的需求
  • 擴展與心臟結構裝置相連的遠端患者監護系統
  • 增加對生物分解性材料的投資，打造更安全的結構性心臟植入
  • 微創結構性心臟裝置技術的進步改善了患者的治療效果
  • 科技公司與醫療科技公司之間的合作加速了設備創新
  • 不斷變化的法規結構正在加速新心臟設備的核准
  • 開發即時成像技術以幫助準確放置心臟結構裝置
  • 拓展結構性心臟裝置在先天性心臟疾病治療的應用
  • 經導管瓣膜治療的成長推動了市場大幅擴張

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. 心臟結構裝置市場（依產品類型）

  • 附屬設備
    • 輸送系統
    • 導管導引線
    • 導引鞘
  • 環狀成形術環
  • 心臟瓣膜裝置
    • 人工心臟瓣膜
    • 組織心臟瓣膜
    • 經導管心臟瓣膜
  • 充填儀器和設備
    • 心房中隔閉合器
    • 左心耳封堵器
    • 卵圓孔未閉閉塞器
    • 室間隔心房中隔閉合器

9. 心臟結構裝置市場（依手術類型）

  • 微創手術
  • 開胸心臟手術

第 10 章。心臟結構裝置市場（依材料類型）

  • 金屬合金
  • 高分子材料
  • 組織材料

第 11 章心臟結構裝置市場（依應用）

  • 外科主動脈瓣置換術
  • 經導管主動脈瓣置換術
  • 經導管二尖瓣瓣膜修復

第 12 章：心臟結構器材市場（依最終用戶）

  • 門診手術中心
  • 醫院
  • 專門的心臟中心

13. 美洲結構性心臟設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 歐洲、中東和非洲結構性心臟器材市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15.亞太地區結構性心臟器材市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Abbott Laboratories
    • AMETEK.Inc.
    • Artivion, Inc.
    • BIOTRONIK SE & Co. KG
    • Boston Scientific Corporation
    • Braile Biomedica Industria, Comercio e Representacoes Ltda.
    • B. Braun Medical Inc.
    • Cardinal Health, Inc.
    • Direct Flow Medical, Inc.
    • Edwards Lifesciences Corporation
    • JenaValve Technology, Inc.
    • Johnson & Johnson Services, Inc.
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • Livanova PLC
    • Medtronic plc
    • Meril Life Sciences Pvt. Ltd.
    • Micro Interventional Devices, Inc.
    • MicroPort Scientific Corporation's
    • Relisys Medical Devices Limited.
    • TE Connectivity Corporation
    • Teleflex Incorporated.
    • Terumo Corporation
    • TTK Healthcare Limited

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-612A4BAA77DA

The Structural Heart Devices Market was valued at USD 21.06 billion in 2024 and is projected to grow to USD 23.01 billion in 2025, with a CAGR of 9.60%, reaching USD 36.51 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 21.06 billion
Estimated Year [2025] USD 23.01 billion
Forecast Year [2030] USD 36.51 billion
CAGR (%) 9.60%

Structural heart device innovations are reshaping the landscape of cardiac care, offering new hope to patients with valve disorders, defect closures, and complex anatomical challenges. As demographic shifts drive greater demand for minimally invasive interventions, medical technology developers continue to refine delivery systems and materials that enhance procedural safety and patient outcomes. In parallel, regulatory bodies are evolving pathways to facilitate accelerated approvals for breakthrough solutions, underscoring the critical interplay between innovation and policy.

In recent years, advances in transcatheter techniques and the refinement of mechanical and tissue valve designs have led to substantial improvements in durability and hemodynamic performance. These technological breakthroughs have been complemented by enhanced imaging modalities and guidewire systems, which collectively support more precise device placement and reduced recovery times. As a result, hospitals and specialty cardiac centers are increasingly adopting integrated procedural protocols that leverage these tools to optimize the continuum of care.

Economic pressures and shifting reimbursement models have emphasized the importance of cost-effectiveness without compromising quality. Consequently, manufacturers are exploring novel materials ranging from advanced polymers to biocompatible alloys, while also investing in next-generation introducer sheaths and occluder configurations. These developments highlight the multifaceted drivers that are propelling the field forward.

This executive summary provides a cohesive exploration of transformative market shifts, tariff implications, segmentation insights, regional dynamics, and strategic recommendations to inform decision makers and guide future investments in structural heart device innovations.

Identifying Transformative Paradigm Shifts in Structural Heart Therapy Driven by Technological Advances, Patient-Centric Care Trends, and Regulatory Milestones Across the Ecosystem

The structural heart device sector is undergoing transformative paradigm shifts, driven by a confluence of technological breakthroughs, patient-centric care models, and evolving regulatory frameworks. As artificial intelligence and machine learning begin to intersect with device development, predictive analytics are enabling more accurate patient selection and personalized therapy protocols. This shift toward data-driven decision making is complemented by the expansion of 3D printing technologies that facilitate patient-specific implant design and rapid prototyping.

Meanwhile, there has been a pronounced movement toward minimally invasive procedures, reflecting growing patient preference for reduced hospitalization and expedited recovery. This trend has prompted developers to optimize delivery systems and guidewire flexibility, thereby enhancing procedural precision. Concurrently, remote monitoring platforms are maturing, allowing clinicians to track post-procedure hemodynamics and detect device-related complications at an early stage. Such capabilities promote proactive clinical management and foster continuous device improvement.

Regulatory milestones are also redefining market entry pathways. Accelerated approval programs, conditional on real-world evidence collection, are expediting access to groundbreaking therapies while maintaining rigorous safety standards. As a result, stakeholders across the ecosystem are recalibrating their strategies to align with both expedited approvals and long-term post-market surveillance commitments. Together, these transformative shifts underscore an era of rapid innovation, heightened collaboration, and patient-centered excellence within the structural heart device landscape.

Assessing the Far-Reaching Implications of United States Tariffs on Structural Heart Device Supply Chains, Cost Structures, Operational Resilience, and Strategic Manufacturing Decisions

United States tariff policies set to take effect in 2025 are poised to exert significant influence on structural heart device supply chains, thereby prompting strategic recalibrations across the industry. Manufacturers heavily reliant on imported components face rising input costs, particularly for specialized metallic alloys and polymer materials sourced from international suppliers. This escalation in procurement expenses necessitates either absorption of incremental costs or transfer of burdens downstream, which could challenge pricing structures and reimbursement negotiations.

In response, many organizations are exploring nearshoring initiatives to establish or expand domestic manufacturing capabilities. Such operational shifts enhance supply chain resilience, mitigate currency fluctuations, and reduce logistical complexities. Yet, these transitions demand substantial capital investment in facility expansion and workforce training. At the same time, partnerships with local contract manufacturers are gaining prominence, offering a more flexible approach to capacity scaling without requiring full vertical integration.

Moreover, tariff-induced cost pressures are catalyzing a renewed emphasis on material innovation. Research into alternative biocompatible substrates and hybrid composites is intensifying, with the goal of preserving performance while lowering dependence on tariff-affected imports. Stakeholders are also consolidating purchasing agreements and leveraging consortium models to negotiate more favorable terms with suppliers. These strategic responses collectively reflect an industry adapting to shifting trade landscapes and striving to protect both profitability and patient access.

Ultimately, the cumulative impact of these tariffs is not uniform but varies by device category and regional operational footprint. Forward-looking companies are engaging in scenario planning to anticipate potential policy adjustments, ensuring that their manufacturing and distribution networks remain robust in the face of evolving trade conditions.

Decoding Critical Segmentation Dimensions Revealing Product, Procedural, Material, Application, and End User Insights Propelling Structural Heart Device Strategies and Outcomes

Critical segmentation insights reveal nuanced opportunities across product, procedure, material, application, and end user dimensions, each informing targeted strategic initiatives. When examining product types, accessory devices such as delivery systems, guidewires, and introducer sheaths demonstrate the value of modular innovation, while heart valve devices encompassing mechanical, tissue, and transcatheter variants highlight evolving preferences toward less invasive implants. Occluders and closure devices, which include atrial septal defect occluders and left atrial appendage closure solutions, further underscore the expanding scope of percutaneous interventions.

Across procedural approaches, the dichotomy between minimally invasive surgery and open-heart surgery speaks to diverging clinical pathways. Minimally invasive techniques continue to gain traction due to shorter hospital stays and lower complication rates, yet open-heart procedures remain integral for complex cases requiring direct visualization. This procedural segmentation ties back to material considerations, where choices among metallic alloys, polymer materials, or tissue-based substrates influence device performance, biocompatibility, and long-term durability.

Application-based segmentation provides additional granularity, as therapies range from surgical aortic valve replacement to transcatheter aortic valve replacement and transcatheter mitral valve repair. Each application's unique anatomical and hemodynamic requirements drive distinct design parameters, procedural protocols, and post-implantation care regimens. Finally, segmentation by end user-including ambulatory surgical centers, hospitals, and specialty cardiac centers-illuminates varying adoption patterns, procurement cycles, and training needs. Together, these segmentation dimensions offer a comprehensive framework for aligning product development, marketing strategies, and clinical engagement initiatives with the dynamic demands of the structural heart device market.

Illuminating Regional Dynamics and Growth Drivers Shaping Structural Heart Device Adoption Patterns across the Americas, Europe Middle East Africa, and Asia-Pacific Markets

Regional dynamics within the structural heart device arena are characterized by distinct growth drivers and adoption patterns across the Americas, Europe Middle East Africa, and Asia-Pacific. In the Americas, advanced healthcare infrastructure and established reimbursement models support swift integration of next-generation transcatheter therapies. Leading hospitals and specialty centers invest heavily in multidisciplinary teams and high-fidelity imaging suites, thereby fostering an environment conducive to procedural innovation and clinical trials. Meanwhile, ambulatory surgical centers are increasingly participating in minimally invasive programs, expanding access to care and reducing overall treatment costs.

In Europe Middle East Africa, heterogeneous regulatory landscapes and variable healthcare funding models influence market penetration rates. Western European nations display robust uptake of percutaneous valves and occlusion devices, driven by concerted policy support and centralized purchasing agreements. At the same time, emerging markets in the Middle East and Africa are experiencing incremental growth, propelled by expanding cardiovascular disease awareness and incremental investments in interventional cardiology training.

The Asia-Pacific region represents a rapidly evolving frontier, fueled by an aging population, rising disposable incomes, and broadening hospital capacities. Countries such as Japan and Australia maintain sophisticated procedural ecosystems, while China and India are accelerating domestic manufacturing capabilities and forging strategic international partnerships. Collectively, these regional insights underscore the importance of tailoring market entry strategies, regulatory navigation plans, and distribution networks to the unique healthcare landscapes that define each geographic cluster.

Uncovering Strategic Movements and Competitive Differentiators among Leading Manufacturers Reshaping the Structural Heart Device Landscape through Innovation and Partnerships

Leading manufacturers are undertaking bold initiatives to maintain competitive differentiation through innovation, strategic collaborations, and targeted acquisitions. Corporations with legacy strength in valve technologies continue to invest in next-generation transcatheter solutions, leveraging decades of clinical data to support device enhancements. Simultaneously, emerging players are entering the market with disruptive materials and proprietary deployment mechanisms, forging partnerships with research institutions to accelerate preclinical validations.

Cross-industry alliances are becoming more prevalent, as technology firms contribute advanced analytics platforms and digital monitoring solutions to established device portfolios. Such collaborations enable remote patient surveillance and real-time procedural guidance, creating holistic ecosystems that extend beyond the cath lab. At the same time, established conglomerates are streamlining operational footprints by divesting non-core assets, redirecting capital toward structural heart programs with the highest strategic impact.

Mergers and acquisitions remain a pivotal strategy for scaling market reach and expanding therapeutic pipelines. By integrating complementary technologies-from polymer innovations to artificial intelligence-driven imaging-companies can offer turnkey solutions that address multiple points along the patient care continuum. This trend underscores the value of a diversified portfolio that blends mechanical, tissue, and transcatheter valve offerings with advanced occluder and closure devices.

Collectively, these competitive maneuvers illustrate an industry in flux, where success hinges on the ability to converge clinical excellence, digital integration, and agile operational models. Stakeholders that manage to balance these elements effectively will be best positioned to shape the next chapter of structural heart interventions.

Strategic Roadmap for Maximizing Market Position: Actionable Recommendations to Propel Growth, Enhance Collaboration, and Drive Innovation in Structural Heart Devices

To navigate the evolving structural heart device environment, industry leaders should prioritize the integration of digital health solutions, enabling remote monitoring platforms and predictive analytics to inform patient selection and post-procedure management. Such investments foster improved clinical outcomes and reinforce long-term device performance through continuous data feedback loops. Moreover, diversifying supply chains by establishing dual sourcing strategies and regional manufacturing hubs will bolster operational resilience in the face of tariff fluctuations and logistical disruptions.

Engagement with regulatory agencies remains critical; proactive collaboration on real-world evidence initiatives and conditional approval pathways can accelerate market access while ensuring robust safety monitoring. Concurrently, seeking strategic alliances and targeted acquisitions will enhance technology portfolios, allowing manufacturers to offer comprehensive procedural suites that span from delivery system innovation to advanced occlusion therapies. By embracing these collaborative models, organizations can achieve economies of scale and reduce time to market.

Finally, centering strategic planning around patient outcomes-through investment in biocompatible materials, minimally invasive delivery platforms, and clinician training programs-will drive differentiation and support favorable reimbursement conversations. Leaders that align business objectives with demonstrable clinical value and operational agility will be poised to capture emerging opportunities and sustain competitive advantage in the structural heart device landscape.

Elucidating Rigorous Research Methodology Underpinning the Comprehensive Structural Heart Device Analysis from Data Collection through Validation, Synthesis, and Expert Review

The research methodology underpinning this structural heart device analysis combines rigorous primary and secondary research phases to ensure comprehensive coverage and data integrity. Primary research involved detailed interviews with cardiologists, interventional specialists, and procurement executives across diverse healthcare settings, complemented by surveys of industry stakeholders to capture sentiment on technological trends, tariff impacts, and regional dynamics.

Secondary research encompassed an exhaustive review of peer-reviewed journals, regulatory filings, clinical trial registries, and company disclosures, providing a robust foundation of historical and contemporary insights. This process was further supported by extraction of device-specific information from patent databases and assessment of regulatory approvals to contextualize market entry timelines and post-market surveillance obligations.

Data validation was conducted through triangulation of multiple sources, including cross-referencing interview feedback with published literature and manufacturer reports. Analytical frameworks were applied to synthesize segmentation dimensions, tariff scenarios, and competitive strategies, ensuring logical coherence and actionable relevance. An expert panel comprising clinical advisors and industry analysts then reviewed draft findings, providing critical input to refine interpretations and validate strategic recommendations.

This multilayered approach guarantees that the insights presented are both empirically grounded and reflective of evolving market realities, equipping decision makers with the clarity needed to navigate the structural heart device space with confidence.

Synthesis of Key Takeaways Highlighting Structural Heart Device Trends, Strategic Imperatives, Innovative Drivers, and Future Directions for Stakeholders and Decision Makers

This executive summary has illuminated the critical trends shaping the structural heart device sector, from transformative technological shifts to the nuanced implications of upcoming tariff policies. Segmentation insights have underscored the importance of aligning product development with procedural preferences, material innovations, and varied end user requirements. Regional analyses have revealed distinct adoption dynamics, highlighting opportunities in established and emerging markets alike.

Key company strategies have demonstrated how innovation ecosystems are coalescing around digital integration, advanced materials research, and strategic partnerships. Actionable recommendations emphasize the need for diversified supply chains, proactive regulatory engagement, and a relentless focus on patient outcomes. By synthesizing these insights, industry leaders can better anticipate market demands, optimize operational resilience, and accelerate the delivery of life-saving therapies.

Looking forward, the structural heart device landscape will continue to evolve in response to demographic pressures, policy shifts, and technological breakthroughs. Stakeholders equipped with timely, evidence-based intelligence will be uniquely positioned to drive sustainable growth, foster clinical excellence, and ultimately improve the lives of patients with complex cardiac conditions. This summary serves as a roadmap for navigating the complexities of a dynamic market and seizing the strategic opportunities that lie ahead.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Increasing focus on patient-specific customization in structural heart device design and delivery
  • 5.2. Rising prevalence of cardiovascular diseases increasing demand for innovative heart devices
  • 5.3. Expansion of remote patient monitoring systems linked to structural heart devices
  • 5.4. Growing investments in biodegradable materials for safer structural heart implants
  • 5.5. Advancements in minimally invasive structural heart device technologies enhancing patient outcomes
  • 5.6. Collaborations among tech companies and medtech firms accelerating device innovation
  • 5.7. Increasing shifts in regulatory frameworks influencing faster approvals of novel heart devices
  • 5.8. Development of real-time imaging technologies aiding precise structural heart device placement
  • 5.9. Expansion of structural heart device applications in treating congenital heart defects
  • 5.10. Growth of transcatheter valve therapies fueling significant market expansion

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Structural Heart Devices Market, by Product Type

  • 8.1. Introduction
  • 8.2. Accessory Devices
    • 8.2.1. Delivery Systems
    • 8.2.2. Guidewires
    • 8.2.3. Introducer Sheaths
  • 8.3. Annuloplasty Rings
  • 8.4. Heart Valve Devices
    • 8.4.1. Mechanical Heart Valves
    • 8.4.2. Tissue Heart Valves
    • 8.4.3. Transcatheter Heart Valves
  • 8.5. Occluders & Closure Devices
    • 8.5.1. Atrial Septal Defect Occluders
    • 8.5.2. Left Atrial Appendage Closure Devices
    • 8.5.3. Patent Foramen Ovale Occluders
    • 8.5.4. Ventricular Septal Defect Occluders

9. Structural Heart Devices Market, by Procedure Type

  • 9.1. Introduction
  • 9.2. Minimally Invasive Surgery
  • 9.3. Open-Heart Surgery

10. Structural Heart Devices Market, by Material Type

  • 10.1. Introduction
  • 10.2. Metallic Alloys
  • 10.3. Polymer Materials
  • 10.4. Tissue Materials

11. Structural Heart Devices Market, by Application

  • 11.1. Introduction
  • 11.2. Surgical Aortic Valve Replacement
  • 11.3. Transcatheter Aortic Valve Replacement
  • 11.4. Transcatheter Mitral Valve Repair

12. Structural Heart Devices Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Hospitals
  • 12.4. Specialty Cardiac Centers

13. Americas Structural Heart Devices Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Structural Heart Devices Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Structural Heart Devices Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. AMETEK.Inc.
    • 16.3.3. Artivion, Inc.
    • 16.3.4. BIOTRONIK SE & Co. KG
    • 16.3.5. Boston Scientific Corporation
    • 16.3.6. Braile Biomedica Industria, Comercio e Representacoes Ltda.
    • 16.3.7. B. Braun Medical Inc.
    • 16.3.8. Cardinal Health, Inc.
    • 16.3.9. Direct Flow Medical, Inc.
    • 16.3.10. Edwards Lifesciences Corporation
    • 16.3.11. JenaValve Technology, Inc.
    • 16.3.12. Johnson & Johnson Services, Inc.
    • 16.3.13. Lepu Medical Technology (Beijing) Co., Ltd.
    • 16.3.14. Livanova PLC
    • 16.3.15. Medtronic plc
    • 16.3.16. Meril Life Sciences Pvt. Ltd.
    • 16.3.17. Micro Interventional Devices, Inc.
    • 16.3.18. MicroPort Scientific Corporation's
    • 16.3.19. Relisys Medical Devices Limited.
    • 16.3.20. TE Connectivity Corporation
    • 16.3.21. Teleflex Incorporated.
    • 16.3.22. Terumo Corporation
    • 16.3.23. TTK Healthcare Limited

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. STRUCTURAL HEART DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. STRUCTURAL HEART DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. STRUCTURAL HEART DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. STRUCTURAL HEART DEVICES MARKET: RESEARCHAI
  • FIGURE 26. STRUCTURAL HEART DEVICES MARKET: RESEARCHSTATISTICS
  • FIGURE 27. STRUCTURAL HEART DEVICES MARKET: RESEARCHCONTACTS
  • FIGURE 28. STRUCTURAL HEART DEVICES MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. STRUCTURAL HEART DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY DELIVERY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY INTRODUCER SHEATHS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY INTRODUCER SHEATHS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ANNULOPLASTY RINGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MECHANICAL HEART VALVES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TISSUE HEART VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TISSUE HEART VALVES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER HEART VALVES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT OCCLUDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT OCCLUDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE CLOSURE DEVICES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE OCCLUDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE OCCLUDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY VENTRICULAR SEPTAL DEFECT OCCLUDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY VENTRICULAR SEPTAL DEFECT OCCLUDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OPEN-HEART SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY OPEN-HEART SURGERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY METALLIC ALLOYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY METALLIC ALLOYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY POLYMER MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY POLYMER MATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TISSUE MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TISSUE MATERIALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY SURGICAL AORTIC VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY SURGICAL AORTIC VALVE REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPAIR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY SPECIALTY CARDIAC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL STRUCTURAL HEART DEVICES MARKET SIZE, BY SPECIALTY CARDIAC CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 76. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 77. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 78. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 79. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 80. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 81. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 83. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 85. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 87. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 89. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 93. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 95. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 96. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 97. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 98. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 99. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 100. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 101. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 103. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 105. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 106. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 107. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES STRUCTURAL HEART DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 111. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 113. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 114. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 115. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 116. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 117. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 118. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 119. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 123. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 125. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. CANADA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 127. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 129. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 130. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 131. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 132. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 133. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 134. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 135. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 137. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 139. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 141. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. MEXICO STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 143. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 145. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 146. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 147. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 148. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 149. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 150. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 151. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 153. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 157. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. BRAZIL STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 159. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 161. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 162. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 163. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 164. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 165. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 166. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 167. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 169. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 171. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 173. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. ARGENTINA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA STRUCTURAL HEART DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 198. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 200. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 203. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 205. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 207. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED KINGDOM STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 209. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 211. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 212. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 213. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 214. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 215. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 216. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 217. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 219. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 221. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 223. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. GERMANY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 225. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 227. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 228. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 229. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 230. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 231. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 232. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 233. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 235. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 239. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. FRANCE STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 241. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 243. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 244. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 245. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 246. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 247. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 248. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 249. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 255. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. RUSSIA STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 257. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 259. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 260. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 261. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 263. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 264. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 265. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 267. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 269. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. ITALY STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 273. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 276. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 277. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 278. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 279. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 280. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 281. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 283. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 287. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. SPAIN STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 289. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 291. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 293. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 294. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 295. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 296. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 297. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
  • TABLE 299. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
  • TABLE 301. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 303. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. UNITED ARAB EMIRATES STRUCTURAL HEART DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 308. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2025-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2018-2024 (USD MILLION)
  • TABLE 310. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY HEART VALVE DEVICES, 2025-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA STRUCTURAL HEART DEVICES MARKET SIZE, BY OCCLUDERS & CLOSURE DEVICES, 201